Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,630.00
Bid: 2,630.00
Ask: 2,635.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.19%)
Open: 2,620.00
High: 2,640.00
Low: 2,620.00
Prev. Close: 2,630.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
1st Aug 20189:47 amRNSTotal Voting Rights
11th Jul 20183:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSNotice of Results
2nd Jul 201811:31 amRNSTotal Voting Rights
4th Jun 20184:34 pmRNSHolding(s) in Company
1st Jun 20184:30 pmRNSTotal Voting Rights
16th May 20188:00 amRNSAdditional Listing
4th May 201812:37 pmRNSResult of AGM
4th May 20187:00 amRNSAGM Trading Update
30th Apr 201810:17 amRNSTotal Voting Rights
23rd Apr 20189:15 amRNSBlock listing Interim Review
17th Apr 20187:00 amRNSMorgan Sindall Group Agrees £2bn Joint Venture
29th Mar 20185:29 pmRNSTotal Voting Rights
26th Mar 201812:25 pmRNSAnnual Financial Report
20th Mar 20182:38 pmRNSHolding(s) in Company
7th Mar 20189:28 amRNSDirector/PDMR Shareholding
7th Mar 20189:27 amRNSDirector/PDMR Shareholding
5th Mar 20183:49 pmRNSDirector/PDMR Shareholding
28th Feb 201811:19 amRNSTotal Voting Rights
26th Feb 20189:43 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
1st Feb 201810:45 amRNSTotal Voting Rights
30th Jan 20182:33 pmRNSHolding(s) in Company
29th Jan 20183:10 pmRNSDirectorate Change
15th Jan 201812:38 pmRNSStatement re: Carillion plc
8th Jan 20187:00 amRNSNotice of Results
3rd Jan 20189:08 amRNSTotal Voting Rights
14th Dec 20178:00 amRNSAdditional Listing
1st Dec 20171:00 pmRNSTotal Voting Rights
1st Dec 201712:37 pmRNSDirector/PDMR Shareholding
28th Nov 20175:13 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSPartnership Homes MOD Contract
24th Nov 20172:55 pmRNSHolding(s) in Company
22nd Nov 20177:00 amRNSAnalyst and Investor Evening Reception
2nd Nov 201712:50 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSTrading Update
31st Oct 20172:03 pmRNSTotal Voting Rights
27th Oct 201710:00 amRNSNotice of Trading Update
23rd Oct 20178:47 amRNSBlock listing Interim Review
2nd Oct 20179:05 amRNSTotal Voting Rights
21st Sep 20178:00 amRNSAdditional Listing
8th Sep 20173:27 pmRNSHolding(s) in Company
6th Sep 20175:22 pmRNSHolding(s) in Company
31st Aug 201712:16 pmRNSTotal Voting Rights
17th Aug 20171:14 pmRNSHolding(s) in Company
17th Aug 201711:12 amRNSHolding(s) in Company
8th Aug 20177:00 amRNSHalf-year Report
4th Aug 20178:45 amRNSHolding(s) in Company
31st Jul 201712:27 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.